These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 20921521)

  • 21. KIR2DL4 (CD158d) polymorphisms and susceptibility to multiple sclerosis.
    Goris A; Dobosi R; Boonen S; Nagels G; Dubois B
    J Neuroimmunol; 2009 May; 210(1-2):113-5. PubMed ID: 19304328
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A PD-1 polymorphism is associated with disease progression in multiple sclerosis.
    Kroner A; Mehling M; Hemmer B; Rieckmann P; Toyka KV; Mäurer M; Wiendl H
    Ann Neurol; 2005 Jul; 58(1):50-7. PubMed ID: 15912506
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Profile of cytokine gene polymorphisms in Iranian multiple sclerosis patients.
    Amirzargar A; Khosravi F; Dianat S; Hushmand F; Maryousef P; Foroushani AR; Lotfi J; Nikbin B
    Mult Scler; 2007 Mar; 13(2):253-5. PubMed ID: 17439892
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Variations of the perforin gene in patients with multiple sclerosis.
    Cappellano G; Orilieri E; Comi C; Chiocchetti A; Bocca S; Boggio E; Bernardone IS; Cometa A; Clementi R; Barizzone N; D'Alfonso S; Corrado L; Galimberti D; Scarpini E; Guerini FR; Caputo D; Paolicelli D; Trojano M; Figà-Talamanca L; Salvetti M; Perla F; Leone M; Monaco F; Dianzani U
    Genes Immun; 2008 Jul; 9(5):438-44. PubMed ID: 18496551
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CTLA4 exon 1 and promoter polymorphisms in patients with multiple sclerosis.
    Yousefipour G; Erfani N; Momtahan M; Moghaddasi H; Ghaderi A
    Acta Neurol Scand; 2009 Dec; 120(6):424-9. PubMed ID: 19737153
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TLR4 haplotypes in multiple sclerosis: a case-control study in the Spanish population.
    Urcelay E; Blanco-Kelly F; de Las Heras V; de la Concha EG; Arroyo R; Martínez A
    J Neuroimmunol; 2007 Dec; 192(1-2):215-8. PubMed ID: 17967488
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interferon gamma allelic variants: sex-biased multiple sclerosis susceptibility and gene expression.
    Kantarci OH; Hebrink DD; Schaefer-Klein J; Sun Y; Achenbach S; Atkinson EJ; Heggarty S; Cotleur AC; de Andrade M; Vandenbroeck K; Pelfrey CM; Weinshenker BG
    Arch Neurol; 2008 Mar; 65(3):349-57. PubMed ID: 18332247
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relevance of IL7R genotype and mRNA expression in Dutch patients with multiple sclerosis.
    Sombekke MH; van der Voort LF; Kragt JJ; Nielsen JM; Guzel H; Visser A; Oudejans CB; Crusius JB; Peña AS; Vrenken H; Polman CH; Killestein J
    Mult Scler; 2011 Aug; 17(8):922-30. PubMed ID: 21543551
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Up-regulated perforin expression of CD8+ blood lymphocytes in generalized non-anaphylactic drug eruptions and exacerbated psoriasis.
    Behrendt C; Gollnick H; Bonnekoh B
    Eur J Dermatol; 2000; 10(5):365-9. PubMed ID: 10882944
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic variants of Complex I in multiple sclerosis.
    Vyshkina T; Banisor I; Shugart YY; Leist TP; Kalman B
    J Neurol Sci; 2005 Jan; 228(1):55-64. PubMed ID: 15607211
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transgenic control of perforin gene expression. Functional evidence for two separate control regions.
    Lichtenheld MG; Podack ER; Levy RB
    J Immunol; 1995 Mar; 154(5):2153-63. PubMed ID: 7868890
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CRYAB promoter polymorphisms: influence on multiple sclerosis susceptibility and clinical presentation.
    Stoevring B; Frederiksen JL; Christiansen M
    Clin Chim Acta; 2007 Jan; 375(1-2):57-62. PubMed ID: 17010329
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gene expression profile in multiple sclerosis patients and healthy controls: identifying pathways relevant to disease.
    Bomprezzi R; Ringnér M; Kim S; Bittner ML; Khan J; Chen Y; Elkahloun A; Yu A; Bielekova B; Meltzer PS; Martin R; McFarland HF; Trent JM
    Hum Mol Genet; 2003 Sep; 12(17):2191-9. PubMed ID: 12915464
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genomic regulation of CTLA4 and multiple sclerosis.
    Palacios R; Comas D; Elorza J; Villoslada P
    J Neuroimmunol; 2008 Oct; 203(1):108-15. PubMed ID: 18691768
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential expression of human granzymes A, B, and K in natural killer cells and during CD8+ T cell differentiation in peripheral blood.
    Bratke K; Kuepper M; Bade B; Virchow JC; Luttmann W
    Eur J Immunol; 2005 Sep; 35(9):2608-16. PubMed ID: 16106370
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Isolation and characterization of CD8+ regulatory T cells in multiple sclerosis.
    Correale J; Villa A
    J Neuroimmunol; 2008 Mar; 195(1-2):121-34. PubMed ID: 18234356
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Perforin and granzyme expression in cytotoxic T-cell lymphomas.
    Yamashita Y; Yatabe Y; Tsuzuki T; Nakayama A; Hasegawa Y; Kojima H; Nagasawa T; Mori N
    Mod Pathol; 1998 Apr; 11(4):313-23. PubMed ID: 9578080
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Frequency of blood CX3CR1-positive natural killer cells correlates with disease activity in multiple sclerosis patients.
    Infante-Duarte C; Weber A; Krätzschmar J; Prozorovski T; Pikol S; Hamann I; Bellmann-Strobl J; Aktas O; Dörr J; Wuerfel J; Stürzebecher CS; Zipp F
    FASEB J; 2005 Nov; 19(13):1902-4. PubMed ID: 16144955
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HLA-DRB1*1501, -DQB1*0301, -DQB1*0302, -DQB1*0602, and -DQB1*0603 alleles are associated with more severe disease outcome on MRI in patients with multiple sclerosis.
    Zivadinov R; Uxa L; Bratina A; Bosco A; Srinivasaraghavan B; Minagar A; Ukmar M; Benedetto Sy; Zorzon M
    Int Rev Neurobiol; 2007; 79():521-35. PubMed ID: 17531857
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The high producer variant of the Fc-receptor like-3 (FCRL3) gene is involved in protection against multiple sclerosis.
    Matesanz F; Fernández O; Milne RL; Fedetz M; Leyva L; Guerrero M; Delgado C; Lucas M; Izquierdo G; Alcina A
    J Neuroimmunol; 2008 Mar; 195(1-2):146-50. PubMed ID: 18313765
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.